National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 3) (Cth)
PB 56 of 2021
National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 3)
I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 27 May 2021
NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 3).
This instrument may also be cited as PB 56 of 2021
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 June 2021. | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021)
1 Schedule 1, entry for Allopurinol in the form Tablet 100 mg
omit from the column headed “Claimed Price”: 7.75 substitute: 8.21
2 Schedule 1, entry for Allopurinol in the form Tablet 300 mg
omit from the column headed “Claimed Price”: 6.51 substitute: 6.98
3 Schedule 1, entry for Candesartan
Omit
| Candesartan | Tablet containing candesartan cilexetil 4 mg | Oral | Atacand | 30 | 0.43 | 12.96 |
| Tablet containing candesartan cilexetil 8 mg | Oral | Atacand | 30 | 1.29 | 13.82 | |
| Tablet containing candesartan cilexetil 32 mg | Oral | Atacand | 30 | 4.64 | 17.17 |
Substitute
| Candesartan | Tablet containing candesartan cilexetil 4 mg | Oral | Atacand | 30 | 0.43 | 12.96 |
| Tablet containing candesartan cilexetil 8 mg | Oral | Atacand | 30 | 1.29 | 13.82 | |
| Tablet containing candesartan cilexetil 16 mg | Oral | Atacand | 30 | 3.84 | 16.37 | |
| Tablet containing candesartan cilexetil 32 mg | Oral | Atacand | 30 | 4.64 | 17.17 |
4 Schedule 1, entry for Diphenoxylate with Atropine in the form Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms
omit from the column headed “Claimed Price”: 3.06 substitute: 4.96
5 Schedule 1, entry for Ezetimibe in the form Tablet 10 mg
omit from the column headed “Claimed Price”: 13.21 substitute: 13.62
6 Schedule 1, entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)
omit from the column headed “Claimed Price”: 14.10 substitute: 14.58
7 Schedule 1, entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)
omit from the column headed “Claimed Price”: 15.70 substitute: 16.03
8 Schedule 1, entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)
omit from the column headed “Claimed Price”: 15.13 substitute: 15.67
9 Schedule 1, entry for Ezetimibe and rosuvastatin in the form Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)
omit from the column headed “Claimed Price”: 16.00 substitute: 16.57
10 Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
omit from the column headed “Claimed Price”: 4.55 substitute: 5.30
11 Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
omit from the column headed “Claimed Price”: 5.69 substitute: 6.36
12 Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
omit from the column headed “Claimed Price”: 8.73 substitute: 9.28
13 Schedule 1, after entry for Felodipine in the form Tablet 10 mg (extended release)
Insert
| Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | 60 | 21.28 | 22.95 |
| Tablet containing flecainide acetate 100 mg | Oral | Tambocor | 60 | 26.38 | 28.05 |
14 Schedule 1, entry for Imiquimod in the form Cream 50 mg per g, 2 g, 2
omit from the column headed “Claimed Price”: 74.48 substitute: 78.01
15 Schedule 1, entry for Imiquimod in the form Cream 50 mg per g, 250 mg single use sachets, 12
omit from the column headed “Claimed Price”: 72.37 substitute: 73.32
16 Schedule 1, entry for Lamivudine in the form Tablet 100 mg
omit from the column headed “Claimed Price”: 35.30 substitute: 36.44
17 Schedule 1, entry for Metoclopramide in the form Tablet containing 10 mg metoclopramide hydrochloride (as monohydrate)
omit from the column headed “Claimed Price”: 2.83 substitute: 4.35
18 Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)
omit from the column headed “Claimed Price”: 10.37 substitute: 10.70
19 Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)
omit from the column headed “Claimed Price”: 10.94 substitute: 11.27
20 Schedule 1, entry for Olmesartan with amlodipine and hydrochlorothiazide in the form Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 8.11 substitute: 8.36
21 Schedule 1, entry for Olmesartan with amlodipine and hydrochlorothiazide in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 11.88 substitute: 12.16
22 Schedule 1, entry for Olmesartan with amlodipine and hydrochlorothiazide in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg
omit from the column headed “Claimed Price”: 13.37 substitute: 13.62
23 Schedule 1, entry for Olmesartan with amlodipine and hydrochlorothiazide in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 12.45 substitute: 12.73
24 Schedule 1, entry for Olmesartan with amlodipine and hydrochlorothiazide in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg
omit from the column headed “Claimed Price”: 13.94 substitute: 14.19
25 Schedule 1, entry for Oxazepam
Omit
| Oxazepam | Tablet 30 mg | Oral | Serepax | 25 | 1.21 | 3.17 |
Substitute
| Oxazepam | Tablet 30 mg | Oral | Murelax | 25 | 1.00 | 1.80 |
| Serepax | 25 | 1.21 | 3.17 |
26 Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
Omit
| Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral | Cholstat 10 | 30 | 1.43 | 4.18 |
| Tablet containing pravastatin sodium 10 mg | Oral | Pravachol | 30 | 1.43 | 4.17 |
Substitute
| Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral | Cholstat 10 | 30 | 1.43 | 4.18 |
| Tablet containing pravastatin sodium 10 mg | Oral | Pravachol | 30 | 1.43 | 4.52 |
27 Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
omit from the column headed “Claimed Price”: 5.02 substitute: 5.37
28 Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
omit from the column headed “Claimed Price”: 6.33 substitute: 6.63
29 Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
omit from the column headed “Claimed Price”: 8.23 substitute: 8.68
30 Schedule 1, entry for Quinapril
Omit
| Quinapril | Tablet 10 mg (as hydrochloride) | Oral | Accupril | 30 | 3.71 | 7.62 |
Substitute
| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | Accupril | 30 | 2.91 | 6.82 |
| Tablet 10 mg (as hydrochloride) | Oral | Accupril | 30 | 3.71 | 7.62 | |
| Tablet 20 mg (as hydrochloride) | Oral | Accupril | 30 | 4.58 | 8.55 |
31 Schedule 1, entry for Rosuvastatin in the form Tablet 5 mg (as calcium)
omit from the column headed “Claimed Price”: 3.09 substitute: 4.56
32 Schedule 1, entry for Rosuvastatin in the form Tablet 10 mg (as calcium)
omit from the column headed “Claimed Price”: 5.16 substitute: 5.98
33 Schedule 1, entry for Rosuvastatin in the form Tablet 20 mg (as calcium)
omit from the column headed “Claimed Price”: 4.94 substitute: 6.34
34 Schedule 1, entry for Rosuvastatin in the form Tablet 40 mg (as calcium)
omit from the column headed “Claimed Price”: 7.07 substitute: 8.65
35 Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg
omit from the column headed “Claimed Price”: 7.01 substitute: 7.39
36 Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg
omit from the column headed “Claimed Price”: 10.45 substitute: 11.07
37 Schedule 1, entry for Trimethoprim in the form Tablet 300 mg
omit from the column headed “Claimed Price”: 5.00 substitute: 5.28
38 Schedule 1, entry for Valaciclovir
Omit
| Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | Valtrex | 10 | 4.42 | 5.47 |
| Valtrex | 30 | 15.36 | ||||
| Valtrex | 42 | 20.67 | ||||
| Valtrex | 100 | 44.64 |
Substitute
| Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | Valtrex | 10 | 4.42 | 7.19 |
| Valtrex | 30 | 15.76 | ||||
| Valtrex | 42 | 21.06 | ||||
| Valtrex | 100 | 47.18 |
0
0
0